Mendelian susceptibility to Immune Disorders
Gene: IFNGR1
Multiple families with dominant and recessive disease reported, reviewed in PMID 15589309. Recessive deficiency, is thought to result in complete loss of cellular response to IFNG and absence of surface IFNGR1 expression. Dominant deficiency is typically due to cytoplasmic domain truncations resulting in accumulation of nonfunctional IFNGR1 proteins that may impede the function of molecules encoded by the wildtype allele, thereby leading to diminished but not absent responsiveness to IFNG.Created: 15 Mar 2022, 7:57 a.m. | Last Modified: 15 Mar 2022, 7:57 a.m.
Panel Version: 0.16
Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Phenotypes
Immunodeficiency 27A, mycobacteriosis, AR, MIM# 209950; Immunodeficiency 27B, mycobacteriosis, AD, MIM# 615978
Publications
Gene: ifngr1 has been classified as Green List (High Evidence).
Phenotypes for gene: IFNGR1 were changed from to Immunodeficiency 27A, mycobacteriosis, AR, MIM# 209950; Immunodeficiency 27B, mycobacteriosis, AD, MIM# 615978
Publications for gene: IFNGR1 were set to
Mode of inheritance for gene: IFNGR1 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal
gene: IFNGR1 was added gene: IFNGR1 was added to Mendelian susceptibility to Immune Disorders_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: IFNGR1 was set to Unknown